Issue 3/2008

Wnt signaling and cancer development: therapeutic implication (165 — 176)

S. PAUL, A. DEY

Contribution of p53, p63, and p73 to the developmental diseases and cancer (177 — 181)

K. TOMKOVA, M. TOMKA, V. ZAJAC

Radiosensitivity of peripheral blood lymphocytes from healthy donors and cervical cancer patients; the correspondence of in vitro data with the clinical outcome (182 — 191)

A. GABELOVA, T. FARKASOVA, S. GURSKA, Z. MACHACKOVA, P. LUKACKO, V. WITKOVSKY

A case-control study of lifestyle and lung cancer associations by histological types (192 — 199)

A. KUBIK, P. ZATLOUKAL, L. TOMASEK, J. DOLEZAL, L. SYLLABOVA, J. KARA, P. KOPECKY, I. PLESKO

NS-398 enhances the efficacy of gemcitabine against lung adenocarcinoma through up-regulation of p21WAF1 and p27KIP1 protein (200 — 204)

X. J. CHEN, W. XIAO, X. QU, S. Y. ZHOU

Genetic alterations in gynecological malignancies (205 — 214)

M. KRKAVCOVA, N. JANCARKOVA, M. JANASHIA, P. FREITAG, J. DUSKOVA

High-dose therapy and autologous stem cell transplantation in patients with diffuse large B-cell lymphoma in first complete or partial remission (215 — 221)

T. PAPAJIK, L. RAIDA, E. FABER, J. VONDRAKOVA, V. PROCHAZKA, Z. KUBOVA, I. SKOUMALOVA, M. JAROSOVA, L. KUCEROVA, M. TICHY, B. PAUCEK, M. MYSLIVECEK, C. NEORAL, I. ORAL, J. JARKOVSKY, L. DUSEK, K. INDRAK

A decision-analytic model for early stage breast cancer: Lumpectomy vs mastectomy (222 — 228)

G. BUYUKDAMGACI-ALOGAN, T. ELELE, M. HAYRAN, M. ERMAN, S. KILICKAP

Evaluation of predictive and prognostic significance of serum TGF-beta1 levels in breast cancer according to HER-2 codon 655 polymorphism (229 — 238)

E. PAPADOPOULOU, K. ANAGNOSTOPOULOS, G. TRIPSIANIS, I. TENTES, S. KAKOLYRIS, G. GALAZIOS, E. SIVRIDIS, K. SIMOPOULOS, A. KORTSARIS

The use of high dose rate endobronchial brachytherapy to palliate symptomatic recurrence of previously irriadiated lung cancer (239 — 245)

M. KUBASZEWSKA, J. SKOWRONEK, A. CHICHEL, M. KANIKOWSKI

Invasive cribriform breast carcinomas in patients with grade 1 and stage IIA (T2 N0 M0) breast cancer strongly express the v3 and v6, but not the v4 isoforms of the metastatic marker CD44 (246 — 255)

F. SALEH, W. RENO

No association of MDM2 T309G polymorphism with susceptibility to Korean gastric cancer patients (256 — 260)

Y. G. CHO, B. J. CHOI, J. H. SONG, C. J. KIM, Z. CAO, S. W. NAM, J. Y. LEE, W. S. PARK

A role of thymidine phosphorylase and P53 tissue protein expression in biology of endometrial cancer (261 — 265)

A. MAZUREK, P. KUC, E. MAZUREK-WADOLKOWSKA, T. LAUDANSKI

Prevalent expression of MHC class I chain-related molecule A in human osteosarcoma (266 — 272)

SM. LU, P. XIAO, L. XUE, LH. CHE, P. YANG, Y. LI, H. QIAO